Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Outcome of open abdominal management following military trauma.

Pengelly S, Berry JEA, Herrick SE, Bowley DM, Carlson GL.

Br J Surg. 2018 Jul;105(8):980-986. doi: 10.1002/bjs.10813. Epub 2018 Mar 30.

PMID:
29601081
2.

LAP-VEGaS Practice Guidelines for Reporting of Educational Videos in Laparoscopic Surgery: A Joint Trainers and Trainees Consensus Statement.

Celentano V, Smart N, McGrath J, Cahill RA, Spinelli A, Obermair A, Hasegawa H, Lal P, Almoudaris AM, Hitchins CR, Pellino G, Browning MG, Ishida T, Luvisetto F, Cingiloglu P, Gash K, Harries R, Harji D, Di Candido F, Cassinotti E, McDermott FD, Berry JEA, Battersby NJ, Platt E, Campain NJ, Keeler BD, Boni L, Gupta S, Griffith JP, Acheson AG, Cecil TD, Coleman MG.

Ann Surg. 2018 Dec;268(6):920-926. doi: 10.1097/SLA.0000000000002725.

PMID:
29509586
3.

Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine.

Hardin MO, Vreeland TJ, Clifton GT, Hale DF, Herbert GS, Greene JM, Jackson DO, Berry JE, Nichols P, Yin S, Yu X, Wagner TE, Peoples GE.

Immunotherapy. 2018 Apr;10(5):373-382. doi: 10.2217/imt-2017-0114.

PMID:
29473470
4.

Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2017 Jun 6;8(23):38075. doi: 10.18632/oncotarget.18369. No abstract available.

5.

The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.

Zerr DM, Weissman SJ, Zhou C, Kronman MP, Adler AL, Berry JE, Rayar J, Myers J, Haaland WL, Burnham CD, Elward A, Newland J, Selvarangan R, Sullivan KV, Zaoutis T, Qin X.

J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):366-375. doi: 10.1093/jpids/piw076.

6.

Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.

Cackowski FC, Eber MR, Rhee J, Decker AM, Yumoto K, Berry JE, Lee E, Shiozawa Y, Jung Y, Aguirre-Ghiso JA, Taichman RS.

J Cell Biochem. 2017 Apr;118(4):891-902. doi: 10.1002/jcb.25768. Epub 2016 Nov 10.

7.

The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2016 Jul 5;7(27):41217-41232. doi: 10.18632/oncotarget.9251. Erratum in: Oncotarget. 2017 Jun 6;8(23 ):38075.

8.

Comparison of molecular detection methods for pertussis in children during a state-wide outbreak.

Qin X, Zerr DM, Kronman MP, Adler AL, Berry JE, Rich S, Buccat AM, Xu M, Englund JA.

Ann Clin Microbiol Antimicrob. 2016 Apr 27;15:28. doi: 10.1186/s12941-016-0142-4.

9.

The Role of Osteoclasts in Early Dissemination of Prostate Cancer Tumor Cells.

Zalucha JL, Jung Y, Joseph J, Wang J, Berry JE, Shiozawa Y, Taichman RS.

J Cancer Stem Cell Res. 2015;3. pii: e1005.

10.

Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.

Shiozawa Y, Eber MR, Berry JE, Taichman RS.

Bonekey Rep. 2015 May 20;4:689. doi: 10.1038/bonekey.2015.57. eCollection 2015. Review.

11.

Tissue engineering a surrogate niche for metastatic cancer cells.

Seib FP, Berry JE, Shiozawa Y, Taichman RS, Kaplan DL.

Biomaterials. 2015 May;51:313-319. doi: 10.1016/j.biomaterials.2015.01.076. Epub 2015 Mar 4.

12.

Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow.

Jung Y, Wang J, Lee E, McGee S, Berry JE, Yumoto K, Dai J, Keller ET, Shiozawa Y, Taichman RS.

Mol Cancer Res. 2015 Jan;13(1):197-207. doi: 10.1158/1541-7786.MCR-14-0118. Epub 2014 Aug 19.

13.

Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.

Kronman MP, Zerr DM, Qin X, Englund J, Cornell C, Sanders JE, Myers J, Rayar J, Berry JE, Adler AL, Weissman SJ.

Diagn Microbiol Infect Dis. 2014 Sep;80(1):87-9. doi: 10.1016/j.diagmicrobio.2014.06.006. Epub 2014 Jun 21.

14.

Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.

Zerr DM, Qin X, Oron AP, Adler AL, Wolter DJ, Berry JE, Hoffman L, Weissman SJ.

Antimicrob Agents Chemother. 2014 Jul;58(7):3997-4004. doi: 10.1128/AAC.02558-14. Epub 2014 May 5.

15.

Molecular pathways: niches in metastatic dormancy.

Yumoto K, Eber MR, Berry JE, Taichman RS, Shiozawa Y.

Clin Cancer Res. 2014 Jul 1;20(13):3384-9. doi: 10.1158/1078-0432.CCR-13-0897. Epub 2014 Apr 22. Review.

16.

A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD.

Yumoto K, Berry JE, Taichman RS, Shiozawa Y.

Cytometry A. 2014 Jun;85(6):548-55. doi: 10.1002/cyto.a.22434. Epub 2014 Apr 3.

17.

Activation of the chromosome 19q microRNA cluster in sporadic and androgenetic-biparental mosaicism-associated hepatic mesenchymal hamartoma.

Kapur RP, Berry JE, Tsuchiya KD, Opheim KE.

Pediatr Dev Pathol. 2014 Mar-Apr;17(2):75-84. doi: 10.2350/13-12-1415-OA.1. Epub 2014 Feb 20.

PMID:
24555441
18.

Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.

Shiozawa Y, McGee S, Pienta MJ, McGregor N, Jung Y, Yumoto K, Wang J, Berry JE, Pienta KJ, Taichman RS.

J Cell Biochem. 2013 Nov;114(11):2471-8. doi: 10.1002/jcb.24592.

19.

Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.

Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra A, Joseph J, Berry JE, McGee S, Lee E, Sun H, Wang J, Jin T, Zhang H, Dai J, Krebsbach PH, Keller ET, Pienta KJ, Taichman RS.

Nat Commun. 2013;4:1795. doi: 10.1038/ncomms2766.

20.

GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.

Taichman RS, Patel LR, Bedenis R, Wang J, Weidner S, Schumann T, Yumoto K, Berry JE, Shiozawa Y, Pienta KJ.

PLoS One. 2013 Apr 24;8(4):e61873. doi: 10.1371/journal.pone.0061873. Print 2013.

21.

Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.

Qin X, Zerr DM, McNutt MA, Berry JE, Burns JL, Kapur RP.

Antimicrob Agents Chemother. 2012 Nov;56(11):5971-81. doi: 10.1128/AAC.01371-12. Epub 2012 Sep 10.

22.

Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.

Jung Y, Shiozawa Y, Wang J, McGregor N, Dai J, Park SI, Berry JE, Havens AM, Joseph J, Kim JK, Patel L, Carmeliet P, Daignault S, Keller ET, McCauley LK, Pienta KJ, Taichman RS.

Neoplasia. 2012 May;14(5):429-39.

23.

Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis.

Park SI, Liao J, Berry JE, Li X, Koh AJ, Michalski ME, Eber MR, Soki FN, Sadler D, Sud S, Tisdelle S, Daignault SD, Nemeth JA, Snyder LA, Wronski TJ, Pienta KJ, McCauley LK.

Cancer Res. 2012 May 15;72(10):2522-32. doi: 10.1158/0008-5472.CAN-11-2928.

24.

The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study.

Soma VL, Qin X, Zhou C, Adler A, Berry JE, Zerr DM.

Infect Drug Resist. 2012;5:75-8. doi: 10.2147/IDR.S30662. Epub 2012 Apr 24.

25.

Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.

Mishra A, Wang J, Shiozawa Y, McGee S, Kim J, Jung Y, Joseph J, Berry JE, Havens A, Pienta KJ, Taichman RS.

Mol Cancer Res. 2012 Jun;10(6):703-12. doi: 10.1158/1541-7786.MCR-11-0569. Epub 2012 Apr 19.

26.

Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.

Novince CM, Koh AJ, Michalski MN, Marchesan JT, Wang J, Jung Y, Berry JE, Eber MR, Rosol TJ, Taichman RS, McCauley LK.

Am J Pathol. 2011 Nov;179(5):2431-42. doi: 10.1016/j.ajpath.2011.07.032. Epub 2011 Sep 21.

27.

Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6.

Pirih FQ, Michalski MN, Cho SW, Koh AJ, Berry JE, Ghaname E, Kamarajan P, Bonnelye E, Ross CW, Kapila YL, Jurdic P, McCauley LK.

PLoS One. 2010 Oct 27;5(10):e13657. doi: 10.1371/journal.pone.0013657.

28.

Secondary abdominal compartment syndrome after military wounding.

Lamb CM, Berry JE, DeMello WF, Cox C.

J R Army Med Corps. 2010 Jun;156(2):102-3.

PMID:
20648947
29.

JunB as a potential mediator of PTHrP actions: new gene targets Ephrin B1 and VCAM-1.

Berry JE, Pettway GJ, Cordell KG, Jin T, Datta NS, McCauley LK.

Oral Dis. 2008 Nov;14(8):713-26. doi: 10.1111/j.1601-0825.2008.01489.x.

30.

Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.

Liao J, Li X, Koh AJ, Berry JE, Thudi N, Rosol TJ, Pienta KJ, McCauley LK.

Int J Cancer. 2008 Nov 15;123(10):2267-78. doi: 10.1002/ijc.23602.

31.

Regulation of cementoblast gene expression by inorganic phosphate in vitro.

Foster BL, Nociti FH Jr, Swanson EC, Matsa-Dunn D, Berry JE, Cupp CJ, Zhang P, Somerman MJ.

Calcif Tissue Int. 2006 Feb;78(2):103-12. Epub 2006 Feb 6.

32.

JunB as a downstream mediator of PTHrP actions in cementoblasts.

Berry JE, Ealba EL, Pettway GJ, Datta NS, Swanson EC, Somerman MJ, McCauley LK.

J Bone Miner Res. 2006 Feb;21(2):246-57. Epub 2005 Nov 7.

33.

Bisphosphonate modulates cementoblast behavior in vitro.

Chun YH, Foster BL, Lukasavage PA, Berry JE, Zhao M, Tenenbaum HC, Somerman MJ.

J Periodontol. 2005 Nov;76(11):1890-900.

34.

Dexamethasone and basic-fibroblast growth factor regulate markers of mineralization in cementoblasts in vitro.

Hakki SS, Nohutcu RM, Hakki EE, Berry JE, Akkaya MS, Somerman MJ.

J Periodontol. 2005 Sep;76(9):1550-8.

35.

PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.

Datta NS, Chen C, Berry JE, McCauley LK.

J Bone Miner Res. 2005 Jun;20(6):1051-64. Epub 2005 Jan 18.

36.

The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts.

Boabaid F, Berry JE, Koh AJ, Somerman MJ, McCcauley LK.

J Periodontol. 2004 Sep;75(9):1247-54.

37.

Leucine-rich amelogenin peptide: a candidate signaling molecule during cementogenesis.

Boabaid F, Gibson CW, Kuehl MA, Berry JE, Snead ML, Nociti FH Jr, Katchburian E, Somerman MJ.

J Periodontol. 2004 Aug;75(8):1126-36.

38.

Cementoblast delivery for periodontal tissue engineering.

Zhao M, Jin Q, Berry JE, Nociti FH Jr, Giannobile WV, Somerman MJ.

J Periodontol. 2004 Jan;75(1):154-61.

39.

Amelogenin: a potential regulator of cementum-associated genes.

Viswanathan HL, Berry JE, Foster BL, Gibson CW, Li Y, Kulkarni AB, Snead ML, Somerman MJ.

J Periodontol. 2003 Oct;74(10):1423-31.

40.

Cementum engineering with three-dimensional polymer scaffolds.

Jin QM, Zhao M, Webb SA, Berry JE, Somerman MJ, Giannobile WV.

J Biomed Mater Res A. 2003 Oct 1;67(1):54-60.

41.

Exploring the origins of cementoblasts and their trigger factors.

Berry JE, Zhao M, Jin Q, Foster BL, Viswanathan H, Somerman MJ.

Connect Tissue Res. 2003;44 Suppl 1:97-102.

PMID:
12952181
42.

Cementoblasts maintain expression of osteocalcin in the presence of mineral trioxide aggregate.

Thomson TS, Berry JE, Somerman MJ, Kirkwood KL.

J Endod. 2003 Jun;29(6):407-12.

PMID:
12814226
43.

Bone morphogenetic protein-2 inhibits differentiation and mineralization of cementoblasts in vitro.

Zhao M, Berry JE, Somerman MJ.

J Dent Res. 2003 Jan;82(1):23-7.

PMID:
12508040
44.

Cementum: a phosphate-sensitive tissue.

Nociti FH Jr, Berry JE, Foster BL, Gurley KA, Kingsley DM, Takata T, Miyauchi M, Somerman MJ.

J Dent Res. 2002 Dec;81(12):817-21.

PMID:
12454094
45.

Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype.

Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ.

J Bone Miner Res. 2002 Aug;17(8):1441-51.

46.

The effect of enamel matrix protein derivative on follicle cells in vitro.

Hakki SS, Berry JE, Somerman MJ.

J Periodontol. 2001 May;72(5):679-87.

47.

Parathyroid hormone-related protein regulates extracellular matrix gene expression in cementoblasts and inhibits cementoblast-mediated mineralization in vitro.

Ouyang H, McCauley LK, Berry JE, Saygin NE, Tokiyasu Y, Somerman MJ.

J Bone Miner Res. 2000 Nov;15(11):2140-53.

48.

Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens.

Berry JE, Murphy CM, Smith GA, Ranasinghe E, Finberg R, Walton J, Brown J, Navarrete C, Metcalfe P, Ouwehand WH.

Br J Haematol. 2000 Sep;110(3):735-42.

PMID:
10997989
49.

Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone-related protein in vitro.

Ouyang H, McCauley LK, Berry JE, D'Errico JA, Strayhorn CL, Somerman MJ.

Arch Oral Biol. 2000 Apr;45(4):293-303.

PMID:
10708669
50.

Employing a transgenic animal model to obtain cementoblasts in vitro.

D'Errico JA, Berry JE, Ouyang H, Strayhorn CL, Windle JJ, Somerman MJ.

J Periodontol. 2000 Jan;71(1):63-72.

Supplemental Content

Loading ...
Support Center